Dyazide Articles
Goldshield buys SB products for L17 mill
8 July 1999
Mylan Receive Approval For Generic Dyazide
24 June 1996
US PRODUCT NEWS IN BRIEF
18 April 1994
THE FUTURE FOR THE US DRUG MARKET
28 February 1994
VITARINE FINED OVER DYAZIDE
11 October 1993
SB BEECHAM RESULTS; EXPLOITS STRENGTHS
1 March 1993
BOLAR FOUNDER SENTENCED
1 February 1993
BOLAR PHARMA IN US TRIAL
4 January 1993
Showing 1-8 of 8 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
